Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.64 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.64 |
| ▸ | MAP4K4 | O95819 | 4/20 | 0.64 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.64 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.64 |
| ▸ | CSNK1A1 | P48729 | 4/20 | 0.64 |
| ▸ | GSK3B | P49841 | 4/20 | 0.64 |
| ▸ | CSNK1G2 | P78368 | 4/20 | 0.64 |
| ▸ | PRKD2 | Q9BZL6 | 4/20 | 0.64 |
| ▸ | CSNK1G1 | Q9HCP0 | 4/20 | 0.64 |
| ▸ | CSNK1G3 | Q9Y6M4 | 4/20 | 0.64 |
| ▸ | GSK3A | P49840 | 3/20 | 0.64 |
| ▸ | TAOK1 | Q7L7X3 | 3/20 | 0.64 |
| ▸ | MINK1 | Q8N4C8 | 3/20 | 0.64 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.64 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.64 |
| ▸ | CDK2 | P24941 | 1/20 | 0.64 |
| ▸ | CLK2 | P49760 | 1/20 | 0.57 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.57 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2746001 | 1.00 | MAPK1 (0.64) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL2745671 | 0.94 | MAPK8 (0.69) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL13838948 | 0.94 | MAPK8 (0.69) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL2746150 | 0.92 | MAPK8 (0.67) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL13838942 | 0.92 | MAPK8 (0.67) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL2746075 | 0.92 | PRKD3 (0.74) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL13022215 | 0.92 | MAPK8 (0.65) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL13838941 | 0.91 | MAPK8 (0.66) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL2746041 | 0.91 | MAPK8 (0.66) | MAPK1PRKD3MAP4K4MAPK8MAPK9 | |
| SCHEMBL2746393 | 0.91 | PRKD3 (0.61) | MAPK1PRKD3MAP4K4MAPK8MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090136499-A1 | RAF Inhibitors and Uses Thereof | ARQULE, INC. (US) | 2009-05-28 | — | — | US | disclosed |
| US-20090136499-A1 | RAF Inhibitors and Uses Thereof | ARQULE, INC. (US) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136499-A1 | RAF Inhibitors and Uses Thereof | BRAF, RAF1, ARAF | MAPK1 254/4885PRKD3 469/4885MAP4K4 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.